Page last updated: 2024-09-03

duocarmycin sa and Breast Cancer

duocarmycin sa has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, N; Donat, U; Gentschev, I; Hess, M; Krewer, B; Seubert, CM; Stritzker, J; Sturm, JB; Szalay, AA; Tietze, LF; von Hof, JM	1

Other Studies

1 other study(ies) available for duocarmycin sa and Breast Cancer

Article	Year
Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA. Cancer gene therapy, 2011, Volume: 18, Issue:1 Topics: Animals; beta-Galactosidase; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Duocarmycins; Female; Humans; Indoles; Mice; Mice, Nude; Microscopy, Fluorescence; Oncolytic Virotherapy; Prodrugs; Pyrroles; Vaccinia virus; Xenograft Model Antitumor Assays	2011

Article

Year

Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.

Cancer gene therapy, 2011, Volume: 18, Issue:1

Topics: Animals; beta-Galactosidase; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Duocarmycins; Female; Humans; Indoles; Mice; Mice, Nude; Microscopy, Fluorescence; Oncolytic Virotherapy; Prodrugs; Pyrroles; Vaccinia virus; Xenograft Model Antitumor Assays

2011